News

This study investigates combining osimertinib and gefitinib in advanced lung cancer with EGFR C797S mutation, showing modest benefits but highlighting tumor resistance and limited efficacy.

This study investigates financial conflicts of interest in the US cancer ecosystem, showing over 50% prevalence across clinical trials, oncologists, and decision-making organizations.

This study examines what types of cells make up areas of abnormal tissue caused by endometriosis, finding that most of these cells come from the body's own immune system rather than uterine tissue. This discovery points toward new treatments that could work by targeting the immune system.